1. Home
  2. FCNCP vs VCEL Comparison

FCNCP vs VCEL Comparison

Compare FCNCP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Citizens BancShares Inc.

FCNCP

First Citizens BancShares Inc.

N/A

Current Price

$18.85

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$39.62

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCNCP
VCEL
Founded
N/A
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.4B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
FCNCP
VCEL
Price
$18.85
$39.62
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $57.75
AVG Volume (30 Days)
12.8K
★ 439.3K
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 60.00
EPS
★ 97.95
N/A
Revenue
★ $9,541,000,000.00
$276,259,000.00
Revenue This Year
N/A
$19.40
Revenue Next Year
N/A
$18.24
P/E Ratio
$0.19
★ N/A
Revenue Growth
N/A
★ 16.45
52 Week Low
$18.84
$28.95
52 Week High
$22.60
$49.32

Technical Indicators

Market Signals
Indicator
FCNCP
VCEL
Relative Strength Index (RSI) 25.38 44.28
Support Level N/A $35.32
Resistance Level $20.64 $41.12
Average True Range (ATR) 0.30 1.20
MACD -0.04 0.16
Stochastic Oscillator 0.93 65.91

Price Performance

Historical Comparison
FCNCP
VCEL

About FCNCP First Citizens BancShares Inc.

First Citizens is a US regional bank with total assets of around $237 billion as of June 30, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing in 2025.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: